FCG Investment Company’s AbbVie ABBV Stock Holding History

FCG Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$633K	Sell	2,515 -7,917	-76%	-$1.7M	0.22%	77
2026 Q1	$2.27M	Buy	+10,432	New	+$2.31M	0.99%	21
2025 Q3	$2.62M	Sell	11,296 -585	-5%	-$119K	1.22%	18
2025 Q2	$2.21M	Sell	11,881 -845	-7%	-$157K	1.15%	20
2025 Q1	$2.67M	Buy	12,726 +518	+4%	+$101K	1.68%	14
2024 Q4	$2.17M	Buy	12,208 +557	+5%	+$102K	1.32%	19
2024 Q3	$2.3M	Buy	11,651 +4,215	+57%	+$787K	1.51%	19
2024 Q2	$1.28M	Sell	7,436 -326	-4%	-$54K	0.97%	27
2024 Q1	$1.41M	Buy	+7,762	New	+$1.34M	1.13%	26

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

FCG Investment Company's ABBV Position: Q2 2026 in Review

FCG Investment Company reduced its AbbVie (ABBV) stake by 76% in Q2 2026, selling an estimated $1.7M and leaving 2,515 shares worth $633K. The position accounts for 0.22% of the portfolio, ranked #77.

FCG Investment Company first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.67M in Q1 2025. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

FCG Investment Company held 2,515 shares of AbbVie worth $633K as of Q2 2026.
FCG Investment Company sold 7,917 AbbVie shares in Q2 2026, an estimated $1.7M.
AbbVie made up 0.22% of FCG Investment Company's portfolio in Q2 2026, its #77 holding.
FCG Investment Company first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
FCG Investment Company's AbbVie position peaked at $2.67M in Q1 2025.
1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.